Menu Back toInstructors

#33: Quality Tolerance Limits/Issue Management: Taming the Beast of Clinical Development Risk


  • Susan  Callery-D'Amico, BSN

    Susan Callery-D'Amico, BSN

    • Vice President, R&D Quality Assurance
    • AbbVie, Inc., United States

    Susan Callery D’Amico is a pharma leader with extensive experience in quality assurance and clinical development. She is the VP, R&D Quality Assurance, AbbVie, with the mission to drive quality excellence and continuous improvement as a strategic advantage across the lifecycle of pharmaceutical products. Susan has held senior management positions in R&D and QA at RWJPRD (J&J), Novarits, and Reata. She has the breadth of drug development experience from early-man through post-marketing.

  • Tim  Grey

    Tim Grey

    • Director,R&D Quality Systems
    • AbbVie, Inc., United States

    Tim Grey joined AbbVie in December 2013. He is currently Director of Research and Development Quality Assurance leading the Quality Systems and Support Services team. Tim has spent his career developing, applying, and implementing quality systems principles across the GxP product development lifecycle. Before joining AbbVie, he was with Eli Lilly and Company in various Quality Assurance positions, including the role of a Lean Six Sigma Black Belt. Early in in his career he had the opportunity to work in the Aerospace industry at Rolls Royce Aerospace where he developed his passion for quality.

Contact us

Registration Questions?

Send Email